Share ownership Trinity Biotech plc

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 05/06/2026 BST			5-day change	1st Jan Change
0.6675 ^USD	-2.43%		-5.02%	-15.61%

06-05	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week	MT
05-26	European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading	MT

Share class: Trinity Biotech plc

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	2	700,000	0	0	96.2 %
Stock B	1	399,318,000	384,810,804 ( 96.37 %)	12,556,000 ( 3.144 %)

Major shareholders: Trinity Biotech plc

Name	Equities	%	Valuation
Hunter Associates Investment Management LLC 2.864 %	536,210	2.864 %	321 726 $
Yorkville Advisors Global LP 1.202 %	225,000	1.202 %	135 000 $
Williams & Novak LLC 0.575 %	107,643	0.575 %	64 586 $
Virtu Financial LLC 0.1425 %	26,676	0.1425 %	16 006 $
Moss Adams Wealth Advisors LLC 0.1371 %	25,666	0.1371 %	15 400 $
Inspirion Wealth Advisors LLC 0.1335 %	25,000	0.1335 %	15 000 $
Cambridge Investment Research, Inc. 0.119 %	22,280	0.119 %	13 368 $
Raymond James & Associates, Inc. 0.1085 %	20,319	0.1085 %	12 191 $
Becker Capital Management, Inc. 0.0962 %	18,000	0.0962 %	10 800 $
Renaissance Technologies LLC 0.0949 %	17,762	0.0949 %	10 657 $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
MiCo IVD Holdings, LLC 53.53 %	44,759,380	53.53 %	7 M $
Ronan O'Caoimh 11.63 %	9,724,160	11.63 %	1 M $
Novus Diagnostics Ltd. 1.34 %	1,119,988	1.34 %	167 998 $
John Gillard 0.2392 %	200,000	0.2392 %	30 000 $
Andrew Omidvar 0 %	0	0 %	- $
Perceptive Advisors LLC 0 %	0	0 %	- $

Breakdown by shareholder type

Others	245.25%
Individuals	53.01%
Institutional	5.56%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	244.82%
Individuals	53.01%
Ireland	5.98%
Switzerland	0.01%

Based on 1000 largest holdings

Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.

Employees

287

Sector

Medical Equipment, Supplies & Distribution

More about the company